On June 25, Intelligent Bio Solutions Inc. (NASDAQ: INBS) trending upwards in after-hours trading. The medical technology company, known for its intelligent, fast, and non-invasive testing solutions, made a significant announcement on June 20. Intelligent Bio Solutions revealed it had successfully signed two major customers in the UK's warehouse and logistics sector over the past three months. These two companies boast a combined workforce of over 15,000 employees across 70 locations.

Both companies will implement Intelligent Bio Solutions' Intelligent Fingerprinting Drug Screening System at most of their UK sites. One of the clients, an award-winning specialist in innovative supply chain solutions, switched to the Intelligent Bio Solutions system due to the inefficiencies of their previous saliva testing method. As covered by Seeking Alpha see entire news article.

On June 19, Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced the completion of patient screening and the start of dosing for its pharmacokinetic (PK) study on fingerprinting drug screening technology. This study will support a 510(K) submission to the U.S. FDA in Q4 2024. The company expects to complete recruitment by the end of June 2024 and review PK study results by the end of July 2024. This announcement follows the company's recent shift to a global operations framework from its UK-based structure. 

Featured by Benzinga alongside GameStop Corp (NYSE: GME), AMC Entertainment (NYSE: AMC), Novavax (NASDAQ: NVAX), Peraso (NASDAQ: PRSO), Intelligent Bio Solutions Inc (NASDAQ: INBS), Dyadic International Inc. (NASDAQ: DYAI) see: GameStop Raises $2.14 Billion, Meme Stocks Buzz Fuels Gains Watch: GME, PRSO, DYAI, VTAK, AMC - AMC Enter Hldgs (NYSE:AMC), Dyadic International (NASDAQ:DYAI) - Benzinga

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com